Stoke Therapeutics Stock (NASDAQ: STOK) stock price, news, charts, stock research, profile.
Open | $13.35 |
Close | $12.94 |
Volume / Avg. | 346.18K / 880.00K |
Day Range | 12.70 - 13.70 |
52 Wk Range | 3.35 - 17.58 |
Market Cap | $674.44M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 24.14% |
Days to Cover | 13.19 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Stoke Therapeutics (NASDAQ:STOK) through any online brokerage.
Other companies in Stoke Therapeutics’s space includes: Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Humacyte (NASDAQ:HUMA), Celcuity (NASDAQ:CELC) and Sage Therapeutics (NASDAQ:SAGE).
There is no analysis for Stoke Therapeutics.
Stoke Therapeutics has a consensus price target of $19.20.
The stock price for Stoke Therapeutics (NASDAQ: STOK) is $12.94 last updated Today at July 8, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Stoke Therapeutics.
Stoke Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Stoke Therapeutics.
Stoke Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.